Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Expressing the Prochemotherapy Position on Treatment of Synchronous Colorectal Metastases in the Asymptomatic Patient

Expressing the Prochemotherapy Position on Treatment of Synchronous Colorectal Metastases in the... Annals of Surgical Oncology, 13(2): 137)139 DOI: 10.1245/ASO.2006.05.059 Controversies in Surgical Oncology Expressing the Prochemotherapy Position on Treatment of Synchronous Colorectal Metastases in the Asymptomatic Patient Nicholas J. Petrelli, MD Helen F. Graham Cancer Center, 4701 Ogletown-Stanton Road, Newark, Delaware 19713 In this new section of the Annals of Surgical ever, to counteract this argument, recent reviews have Oncology, entitled ‘‘Controversies in Surgical Oncol- demonstrated that the potential complications of ogy,’’ the present topic is ‘‘Treatment of Synchronous leaving the primary tumor intact have been over- Colorectal Metastases in the Asymptomatic Patient: stated and seem limited to risks of colonic Resection of the Primary Tumor With Postoperative obstruction in the range of 10% to 20%, gastroin- Chemotherapy or Immediate Neoadjuvant Chemo- testinal hemorrhage (4%), and fistula formation 3–5 4 therapy.’’ I will take the prochemotherapy position (4%). A recent article by Tebbutt et al. compared and defend the fact that in this group of asymptom- the incidence of major intestinal complications in atic patients who present with a primary colorectal patients who received chemotherapy treatment with cancer in the presence of distant metastases, it is not or without prior palliative resection of the primary necessary to perform surgery on http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Surgical Oncology Springer Journals

Expressing the Prochemotherapy Position on Treatment of Synchronous Colorectal Metastases in the Asymptomatic Patient

Petrelli, Nicholas
Annals of Surgical Oncology , Volume 13 (2) – Jan 18, 2006
Download PDF
3 pages

Loading next page...
 
/lp/springer-journals/expressing-the-prochemotherapy-position-on-treatment-of-synchronous-Q5Tru8QRVu

References (9)

Publisher
Springer Journals
Copyright
Copyright © 2006 by The Society of Surgical Oncology, Inc.
Subject
Medicine & Public Health; Surgery; Oncology; Surgical Oncology
ISSN
1068-9265
eISSN
1534-4681
DOI
10.1245/ASO.2006.05.059
pmid
16418888
Publisher site
See Article on Publisher Site

Abstract

Annals of Surgical Oncology, 13(2): 137)139 DOI: 10.1245/ASO.2006.05.059 Controversies in Surgical Oncology Expressing the Prochemotherapy Position on Treatment of Synchronous Colorectal Metastases in the Asymptomatic Patient Nicholas J. Petrelli, MD Helen F. Graham Cancer Center, 4701 Ogletown-Stanton Road, Newark, Delaware 19713 In this new section of the Annals of Surgical ever, to counteract this argument, recent reviews have Oncology, entitled ‘‘Controversies in Surgical Oncol- demonstrated that the potential complications of ogy,’’ the present topic is ‘‘Treatment of Synchronous leaving the primary tumor intact have been over- Colorectal Metastases in the Asymptomatic Patient: stated and seem limited to risks of colonic Resection of the Primary Tumor With Postoperative obstruction in the range of 10% to 20%, gastroin- Chemotherapy or Immediate Neoadjuvant Chemo- testinal hemorrhage (4%), and fistula formation 3–5 4 therapy.’’ I will take the prochemotherapy position (4%). A recent article by Tebbutt et al. compared and defend the fact that in this group of asymptom- the incidence of major intestinal complications in atic patients who present with a primary colorectal patients who received chemotherapy treatment with cancer in the presence of distant metastases, it is not or without prior palliative resection of the primary necessary to perform surgery on

Journal

Annals of Surgical Oncology – Springer Journals

Published: Jan 18, 2006

There are no references for this article.